Stock MYNZ MAINZ BIOMED N.V.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Mainz Biomed N.V.

Equities

MYNZ

NL0015000LC2

Healthcare Facilities & Services

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-06-07 pm EDT 		5-day change 1st Jan Change
0.798 USD +3.64% Intraday chart for Mainz Biomed N.V. -8.19% -31.21%
May. 07 Mainz Biomed N.V. Presents an Analysis from Its eAArly Detect Study At Digestive Disease Week CI
Apr. 25 Mainz Biomed Reports Positive Topline Results from Pooled Study Evaluating Novel Mrna Biomarkers and Proprietary Ai Algorithm for Integration into Pivotal FDA PMA Clinical Trial for Next Generation Colorectal Cancer Diagnostic CI

Valuation

Fiscal Period: December 2021 2022 2023 2024 2025 2026
Capitalization 1 124.8 102.9 23.62 17.47 - -
Enterprise Value (EV) 1 124.8 102.9 23.62 17.47 17.47 17.47
P/E ratio -6.41 x -3.82 x -0.72 x -1 x -1.26 x -1.49 x
Yield - - - - - -
Capitalization / Revenue - 194 x 26.4 x 11.9 x 4.08 x 1.34 x
EV / Revenue - 194 x 26.4 x 11.9 x 4.08 x 1.34 x
EV / EBITDA - - - - - -
EV / FCF - - - -0.36 x -0.27 x -0.32 x
FCF Yield - - - -280% -370% -311%
Price to Book - - - - - -
Nbr of stocks (in thousands) 12,010 14,493 20,358 21,887 - -
Reference price 2 10.39 7.100 1.160 0.7980 0.7980 0.7980
Announcement Date 5/3/22 4/7/23 4/9/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2021 2022 2023 2024 2025 2026
Net sales 1 - 0.5299 0.8955 1.47 4.278 12.99
EBITDA - - - - - -
EBIT 1 - -26.51 -26.64 -33.6 -45.94 -41.09
Operating Margin - -5,002.91% -2,975.46% -2,286.41% -1,073.9% -316.44%
Earnings before Tax (EBT) 1 - -26.39 -26.3 -33.8 -46.19 -41.39
Net income 1 -11.69 -26.39 -26.3 -33.8 -46.19 -41.39
Net margin - -4,979.87% -2,936.5% -2,300.02% -1,079.75% -318.75%
EPS 2 -1.620 -1.860 -1.620 -0.7967 -0.6350 -0.5350
Free Cash Flow 1 - - - -48.97 -64.58 -54.27
FCF margin - - - -3,332.11% -1,509.49% -417.9%
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 5/3/22 4/7/23 4/9/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2022 Q2 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales 1 0.12 0.2501 0.249 0.1817 0.2148 0.2507 0.333 0.4153 0.471 1.207
EBITDA - - - - - - - - - -
EBIT 1 -6.29 -6.488 -7.926 -5.641 -6.59 -6.782 -7.495 -9.011 -10.31 -17.84
Operating Margin -5,241.67% -2,593.99% -3,183.81% -3,104.88% -3,068.73% -2,705.42% -2,250.85% -2,169.68% -2,189.95% -1,477.8%
Earnings before Tax (EBT) 1 - -6.561 -8.252 -6.3 -5.183 -6.815 -7.529 -9.078 -10.38 -17.84
Net income 1 - -6.561 -8.252 -6.3 -5.183 -6.815 -7.529 -9.078 -10.38 -17.84
Net margin - -2,623.32% -3,314.61% -3,467.69% -2,413.55% -2,718.71% -2,260.86% -2,185.73% -2,204.1% -1,477.8%
EPS 2 - -0.4500 -0.5600 -0.3900 -0.2400 -0.2867 -0.2000 -0.1733 -0.1833 -0.1700
Dividend per Share - - - - - - - - - -
Announcement Date 9/7/22 5/16/23 8/15/23 11/16/23 4/9/24 - - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2021 2022 2023 2024 2025 2026
Net Debt - - - - - -
Net Cash position - - - - - -
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 1 - - - -49 -64.6 -54.3
ROE (net income / shareholders' equity) - - - - - -
ROA (Net income/ Total Assets) - - - - - -
Assets 1 - - - - - -
Book Value Per Share - - - - - -
Cash Flow per Share - - - - - -
Capex 1 - 0.66 - 0.92 1.11 1.35
Capex / Sales - 124.27% - 62.33% 26.02% 10.42%
Announcement Date 5/3/22 4/7/23 4/9/24 - - -
1USD in Million
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Ratings for Mainz Biomed N.V.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
3
Last Close Price
0.798 USD
Average target price
3 USD
Spread / Average Target
+275.94%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Medical & Diagnostic Laboratories

1st Jan change Capi.
MAINZ BIOMED N.V. Stock Mainz Biomed N.V.
-31.21% 17.47M
SONIC HEALTHCARE LIMITED Stock Sonic Healthcare Limited
-22.13% 7.9B
RADNET, INC. Stock RadNet, Inc.
+76.16% 4.53B
DR. LAL PATHLABS LIMITED Stock Dr. Lal PathLabs Limited
+8.56% 2.78B
GUANGZHOU KINGMED DIAGNOSTICS GROUP CO., LTD. Stock Guangzhou Kingmed Diagnostics Group Co., Ltd.
-50.41% 1.99B
NEOGENOMICS, INC. Stock NeoGenomics, Inc.
-19.59% 1.66B
FLEURY S.A. Stock Fleury S.A.
-20.07% 1.49B
METROPOLIS HEALTHCARE LIMITED Stock Metropolis Healthcare Limited
+19.31% 1.23B
DIAN DIAGNOSTICS GROUP CO.,LTD. Stock Dian Diagnostics Group Co.,Ltd.
-45.78% 1.1B
VIJAYA DIAGNOSTIC CENTRE LIMITED Stock Vijaya Diagnostic Centre Limited
+20.02% 996M
Medical & Diagnostic Laboratories
  1. Stock Market
  2. Equities
  3. MYNZ Stock
  4. Financials Mainz Biomed N.V.